-+ 0.00%
-+ 0.00%
-+ 0.00%

PURETECH HEALTH - LYT-200 SHOWS FAVORABLE TOLERABILITY AND EFFICACY IN PHASE 1B TRIAL

路透·12/05/2025 18:00:00

登录查看新闻详情